Literature DB >> 2418778

Susceptibility of feline herpesvirus 1 and a feline calicivirus to feline interferon and recombinant human leukocyte interferons.

R W Fulton, L J Burge.   

Abstract

Feline lung monolayer cultures were treated with either a feline interferon (IFN) or one of two recombinant human alpha-IFNs and then challenged with feline herpesvirus 1 (FHV-1), feline calicivirus (F-9 strain), or vesicular stomatitis virus. Treatment with these IFNs reduced the viral yield for each of these three viruses as compared with that of control cultures. Vesicular stomatitis virus was more sensitive to each IFN than were FHV-1 or feline calicivirus F-9.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2418778      PMCID： PMC176362          DOI： 10.1128/AAC.28.5.698

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  In vitro antiviral efficacy of ribavirin against feline calicivirus, feline viral rhinotracheitis virus, and canine parainfluenza virus.

Authors:  R C Povey
Journal:  Am J Vet Res       Date:  1978-01       Impact factor: 1.156

Review 2.  Infectious respiratory diseases of cats.

Authors:  D E Kahn; E A Hoover
Journal:  Vet Clin North Am       Date:  1976-08

3.  Suppression of gamma interferon production by inactivated feline leukemia virus.

Authors:  R W Engelman; R W Fulton; R A Good; N K Day
Journal:  Science       Date:  1985-03-15       Impact factor: 47.728

4.  Cat interferon inhibits feline leukaemia virus infection in cell culture.

Authors:  R Rogers; T C Merigan; W D Hardy; L J Old; R Kassel
Journal:  Nat New Biol       Date:  1972-06-28

5.  Interferon production by bovine tracheal organ cultures infected with bovid herpesvirus 1 strains.

Authors:  R W Fulton; N J Pearson
Journal:  Can J Comp Med       Date:  1980-10

6.  Antiviral and protein-inducing activities of recombinant human leukocyte interferons and their hybrids.

Authors:  G C Sen; R Herz; V Davatelis; S Pestka
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

7.  Specific molecular activities of recombinant and hybrid leukocyte interferons.

Authors:  E Rehberg; B Kelder; E G Hoal; S Pestka
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

8.  Effect of orally administered ribavirin on experimental feline calicivirus infection in cats.

Authors:  R C Povey
Journal:  Am J Vet Res       Date:  1978-08       Impact factor: 1.156

9.  In vitro interferon production by bovine tissues: induction with infectious bovine rhinotracheitis virus.

Authors:  R W Fulton; B D Rosenquist
Journal:  Am J Vet Res       Date:  1976-12       Impact factor: 1.156

10.  Inhibition of feline leukemia virus replication by human leukocyte interferon.

Authors:  P Jameson; M Essex
Journal:  Antiviral Res       Date:  1983-08       Impact factor: 5.970
View more
  8 in total

1.  Antiproliferation and colony-forming inhibition activities of recombinant feline interferon (rFeIFN) on various cells in vitro.

Authors:  B P Priosoeryanto; S Tateyama; R Yamaguchi; K Uchida
Journal:  Can J Vet Res       Date:  1995-01       Impact factor: 1.310

Review 2.  Calicivirus Infection in Cats.

Authors:  Regina Hofmann-Lehmann; Margaret J Hosie; Katrin Hartmann; Herman Egberink; Uwe Truyen; Séverine Tasker; Sándor Belák; Corine Boucraut-Baralon; Tadeusz Frymus; Albert Lloret; Fulvio Marsilio; Maria Grazia Pennisi; Diane D Addie; Hans Lutz; Etienne Thiry; Alan D Radford; Karin Möstl
Journal:  Viruses       Date:  2022-04-29       Impact factor: 5.818

3.  Identification of regions and residues in feline junctional adhesion molecule required for feline calicivirus binding and infection.

Authors:  Robert J Ossiboff; John S L Parker
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

4.  Sensitivity of FCV to recombinant feline interferon (rFeIFN).

Authors:  Kyoko Ohe; Toshikazu Takahashi; Daisuke Hara; Motonobu Hara
Journal:  Vet Res Commun       Date:  2007-10-02       Impact factor: 2.816

5.  Antiviral effect of mefloquine on feline calicivirus in vitro.

Authors:  Phillip McDonagh; Paul A Sheehy; Anne Fawcett; Jacqueline M Norris
Journal:  Vet Microbiol       Date:  2015-02-16       Impact factor: 3.293

Review 6.  The Use of Recombinant Feline Interferon Omega Therapy as an Immune-Modulator in Cats Naturally Infected with Feline Immunodeficiency Virus: New Perspectives.

Authors:  Rodolfo Oliveira Leal; Solange Gil
Journal:  Vet Sci       Date:  2016-10-27

7.  Identification of Feline Interferon Regulatory Factor 1 as an Efficient Antiviral Factor against the Replication of Feline Calicivirus and Other Feline Viruses.

Authors:  Yongxiang Liu; Xiaoxiao Liu; Hongtao Kang; Xiaoliang Hu; Jiasen Liu; Jin Tian; Liandong Qu
Journal:  Biomed Res Int       Date:  2018-06-12       Impact factor: 3.411

8.  Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro.

Authors:  M Mochizuki; H Nakatani; M Yoshida
Journal:  Vet Microbiol       Date:  1994-03       Impact factor: 3.293
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.